Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Concord Drugs Ltd banner
C

Concord Drugs Ltd
BSE:538965

Watchlist Manager
Concord Drugs Ltd
BSE:538965
Watchlist
Price: 66.91 INR 1.39%
Market Cap: ₹881.9m
Write Note Create Alert

Intrinsic Value

538965 price has not been updated for more than 3 years. This may indicate that the stock has been delisted.
538965 doesn't have a meaningful market cap.

Is CONCORD undervalued or overvalued?

See the intrinsic value estimate for Concord Drugs Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

CONCORD Intrinsic Value
LOCKED
Unlock
Today vs. history

CONCORD looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with CONCORD’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CONCORD
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price ₹66.91
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CONCORD

Fundamental Analysis

What Concord Drugs Does

Pharmaceuticals Health Care

Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2015-02-23. The firm is engaged in manufacturing of licensed drugs based on the formulations approved. The firm offers finished pharmaceutical formulations, such as injectables (small volume parenteral, dry powders), tissue bio-adhesive, tablets, capsules, liquid orals (syrup & suspension) and dry syrups (powder).

Headquarters
India IN
IPO date
Feb 23, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Concord Drugs Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue CONCORD Research

Summary
CONCORD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CONCORD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CONCORD stock valuation using valuation multiples.
Wall St Estimates
CONCORD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CONCORD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Discover More
What is the Intrinsic Value of one CONCORD stock?

The intrinsic value for Concord Drugs Ltd (538965) under the Base Case is hidden INR.

Is CONCORD stock undervalued or overvalued?

Compared with the current market price of 66.91 INR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.